Elevance Health Inc.ELVNYSE
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+8.3%
5Y CAGR+11.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+8.3%/yr
vs +12.9%/yr prior
5Y CAGR
+11.0%/yr
Consistent
Acceleration
-4.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $148.22B | +16.2% |
| 2024 | $127.57B | +2.6% |
| 2023 | $124.33B | +6.6% |
| 2022 | $116.64B | +13.6% |
| 2021 | $102.64B | +16.6% |
| 2020 | $88.05B | +7.7% |
| 2019 | $81.79B | +13.8% |
| 2018 | $71.89B | -0.5% |
| 2017 | $72.24B | +8.1% |
| 2016 | $66.83B | - |